Your account is not claimed yet. You can sign up with ORCID to claim your account.

Christopher W Schultz

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Venues

Molecular cancer therapeutics

Biomedicines

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer research : MCR

Thomas Jefferson University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Thomas Jefferson University Aug 1o 2015 - Oct 28o 2019

United States

PHD :: Surgery

Publications

Melissa L Abel, Nobuyuki Takahashi, Cody J Peer, Christophe E Redon, Samantha Nichols, Rasa Vilimas, Min-Jung Lee, Min-Jung Lee, Meenakshi Shelat, Robbie Kattappuram, Linda Sciuto, Danielle Pinkiert, Chante Graham, Donna Butcher, Baktiar O Karim, Ajit Kumar Sharma, Justin Malin, Rajesh Kumar, Christopher W Schultz, Shubhank Goyal, Jaydira Del Rivero, Manan Krishnamurthy, Deep Upadhyay, Brett A Schroeder, Tristan M Sissung, Manoj Tyagi, Jung Kim, Yves Pommier, Mirit I Aladjem, Mark Raffeld, William Douglas Figg, Jane Trepel, Liqiang Xi, Parth Desai, Anish Thomas
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Melissa L Abel, Nobuyuki Takahashi, Cody J Peer, Christophe E Redon, Samantha Nichols, Rasa Vilimas, Min-Jung Lee, Min-Jung Lee, Meenakshi Shelat, Robbie Kattappuram, Linda Sciuto, Danielle Pinkiert, Chante Graham, Donna Butcher, Baktiar O Karim, Ajit Kumar Sharma, Justin Malin, Rajesh Kumar, Christopher W Schultz, Shubhank Goyal, Jaydira Del Rivero, Manan Krishnamurthy, Deep Upadhyay, Brett A Schroeder, Tristan M Sissung, Manoj Tyagi, Jung Kim, Yves Pommier, Mirit I Aladjem, Mark Raffeld, William Douglas Figg, Jane Trepel, Liqiang Xi, Parth Desai, Anish Thomas
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Lorinc Sandor Pongor, Christopher W Schultz, Lorenzo Rinaldi, Darawalee Wangsa, Christophe E Redon, Nobuyuki Takahashi, Gavriel Fialkoff, Parth Desai, Yang Zhang, Sandra Sczerba Burkett, Nadav Hermoni, Noa Vilk, Jenia Gutin, Gergely Rona, Yongmei Zhao, Samantha Nichols, Rasa Vilimas, Linda Sciuto, Chante Graham, Juan Manuel Caravaca, Sevilay Turan, Tsai-Wei Shen, Vinodh N Rajapakse, Rajesh Kumar, Deep Upadhyay, Suresh Kumar, Yoo-Sun Kim, Nitin Roper, Bao Tran, Stephen M Hewitt, David E Kleiner, Mirit I Aladjem, Nir Friedman, Gordon L Hager, Yves Pommier, Thomas Ried, Anish Thomas
Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and is Associated with Worse Outcomes. Cancer discovery (2023)
Francesca M Ponzini, Christopher W Schultz, Benjamin E Leiby, Shawnna Cannaday, T Yeo, James Posey, Wilbur B Bowne, Charles Yeo, Jonathan R Brody, Harish Lavu, Avinoam Nevler
Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase I clinical trial in early-stage pancreatic ductal adenocarcinoma. BMJ open 13 (10) (2023)
Christopher W Schultz, Yang Zhang, Rajaa El Meskini, Astrid Zimmermann, Haiqing Fu, Yasuhisa Murai, Darawalee Wangsa, Suresh Kumar, Nobuyuki Takahashi, Devon A Atkinson, Liton Kumar Saha, Chien-Fei Lee, Brian Elenbaas, Parth Desai, Robin Sebastian, Ajit Kumar Sharma, Melissa Abel, Brett A Schroeder, Manan Krishnamurthy, Rajesh Kumar, Nitin Roper, Mirit I Aladjem, Frank T Zenke, Zoe Weaver Ohler, Yves Pommier, Anish Thomas
ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer. EMBO molecular medicine (2023)
Christopher W Schultz, Avinoam Nevler
Pyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer Drug. Biomedicines 10 (12) (2022)
Yilun Sun, Yang Zhang, Christopher W Schultz, Yves Pommier, Anish Thomas
CDK7 Inhibition Synergizes with Topoisomerase I Inhibition in Small Cell Lung Cancer Cells by Inducing Ubiquitin-Mediated Proteolysis of RNA Polymerase II. Molecular cancer therapeutics 21 (9) (2022)
Christopher W Schultz, Avinoam Nevler
Pyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer Drug. Biomedicines 10 (12) (2022)
Ukhyun Jo, Ilya S Senatorov, Astrid Zimmermann, Liton Kumar Saha, Yasuhisa Murai, Se Hyun Kim, Vinodh N Rajapakse, Fathi Elloumi, Nobuyuki Takahashi, Christopher W Schultz, Anish Thomas, Frank T Zenke, Yves Pommier
Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents. Molecular cancer therapeutics 20 (8) (2021)
Christopher W Schultz, Grace A McCarthy, Teena Nerwal, Avinoam Nevler, James B DuHadaway, Matthew D McCoy, Wei Jiang, Samantha Z Brown, Austin Goetz, Aditi Jain, Valerie S Calvert, Vikalp Vishwakarma, Dezhen Wang, Ranjan Preet, Joel Cassel, Ross Summer, Hoora Shaghaghi, Yves Pommier, Simone A Baechler, Michael J Pishvaian, Talia Golan, Charles J Yeo, Emanuel F Petricoin, George C Prendergast, Joseph M Salvino, Pankaj K Singh, Dan A Dixon, Jonathan R Brody
The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria. Molecular cancer therapeutics 20 (11) (2021)
Christopher W Schultz, Gorka Ruiz de Garibay, Anika Langer, Ji-Bin Liu, Teena Dhir, Calum Leitch, Corinne E Wessner, Mireia Mayoral, Bo Zhang, Mihaela Popa, Chunwang Huang, Spiros Kotopoulis, Xianghong Luo, Yanhua Zhen, Sihua Niu, Mehnoosh Torkzaban, Kirk Wallace, John R Eisenbrey, Jonathan R Brody, Emmet McCormack, Flemming Forsberg
Selecting the optimal parameters for sonoporation of pancreatic cancer in a pre-clinical model. Cancer biology & therapy 22 (3) (2021)
Samantha A Armstrong, Christopher W Schultz, Ariana Azimi-Sadjadi, Jonathan R Brody, Michael J Pishvaian
ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications. Molecular cancer therapeutics 18 (11) (2020)
Aditi Jain, Lebaron C Agostini, Grace A McCarthy, Saswati N Chand, AnnJosette Ramirez, Avinoam Nevler, Joseph Cozzitorto, Christopher W Schultz, Cinthya Yabar Lowder, Kate M Smith, Ian D Waddell, Maria Raitses-Gurevich, Chani Stossel, Yulia Glick Gorman, Dikla Atias, Charles J Yeo, Jordan M Winter, Kenneth P Olive, Talia Golan, Michael J Pishvaian, Donald Ogilvie, Dominic I James, Allan M Jordan, Jonathan R Brody
Poly (ADP) Ribose Glycohydrolase Can Be Effectively Targeted in Pancreatic Cancer. Cancer research 79 (17) (2019)
Teena Dhir, Christopher W Schultz, Aditi Jain, Samantha Z Brown, Alex Haber, Austin Goetz, Chunhua Xi, Gloria H Su, Liang Xu, James Posey, Wei Jiang, Charles J Yeo, Talia Golan, Michael J Pishvaian, Jonathan R Brody
Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition. Molecular cancer research : MCR 17 (10) (2019)

Christopher W Schultz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Christopher W Schultz